Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1;3(5):e206016.
doi: 10.1001/jamanetworkopen.2020.6016.

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care

Affiliations

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care

Julie Kanter et al. JAMA Netw Open. .

Abstract

Importance: Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the United States, and previous studies have shown that individuals with SCD are affected by multiple health disparities, including stigmatization, inequities in funding, and worse health outcomes, which may preclude their ability to access quality health care. This needs assessment was performed as part of the Sickle Cell Disease Implementation Consortium (SCDIC) to assess barriers to care that may be faced by individuals with SCD.

Objective: To assess the SCD-related medical care experience of adolescents and adults with SCD.

Design, setting, and participants: This one-time survey study evaluated pain interference, quality of health care, and self-efficacy of 440 adults and adolescents (aged 15 to 50 years) with SCD of all genotypes and assessed how these variables were associated with their perceptions of outpatient and emergency department (ED) care. The surveys were administered once during office visits by trained study coordinators at 7 of 8 SCDIC sites in 2018.

Results: The SCDIC sites did not report the number of individuals approached to participate in this study; thus, a response rate could not be calculated. In addition, respondents were not required to answer every question in the survey; thus, the response rate per question differed for each variable. Of 440 individuals with SCD, participants were primarily female (245 [55.7%]) and African American (428 [97.3%]) individuals, with a mean (SD) age of 27.8 (8.6) years. The majority of participants (306 of 435 [70.3%]) had hemoglobin SS or hemoglobin S β0-thalassemia. Most respondents (361 of 437 [82.6%]) reported access to nonacute (usual) SCD care, and the majority of respondents (382 of 413 [92.1%]) noted satisfaction with their usual care physician. Of 435 participants, 287 (66.0%) reported requiring an ED visit for acute pain in the previous year. Respondents were less pleased with their ED care than their usual care clinician, with approximately half (146 of 287 [50.9%]) being satisfied with or perceiving having adequate quality care in the ED. Participants also noted that when they experienced severe pain or clinician lack of empathy, this was associated with a negative quality of care. Age group was associated with ED satisfaction, with younger patients (<19 vs 19-30 and 31-50 years) reporting better ED experiences.

Conclusions and relevance: These results suggested that a negative perception of care may be a barrier for patients seeking care. These findings underscore the necessity of implementation studies to improve access to quality care for this population, especially in the acute care setting.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Kanter reported receiving grants from the Medical University of South Carolina and from the National Institutes of Health (NIH) during the conduct of the study and receiving personal fees from Novartis and from Bluebird Bio outside the submitted work. Dr Gibson reported receiving grants from the NIH during the conduct of the study. Dr Smeltzer reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the study. Dr Glassberg reported receiving grants from NHLBI during the conduct of the study and grants from Pfizer outside the submitted work. Dr King reported receiving grants from NHLBI during the conduct of the study. Dr Hankins reported receiving grants from NHLBI during the conduct of the study; receiving research support from Novartis, from Global Blood Therapeutics, and from the Links Foundation; and receiving consultant fees from MJH Life Sciences. Dr Treadwell reported receiving grants from NHLBI during the conduct of the study and personal fees from Global Blood Therapeutics and from Pfizer outside the submitted work. No other disclosures were reported.

Comment in

Similar articles

Cited by

References

    1. DiMartino LD, Baumann AA, Hsu LL, et al. ; Sickle Cell Disease Implementation Consortium . The Sickle Cell Disease Implementation Consortium: translating evidence-based guidelines into practice for sickle cell disease. Am J Hematol. 2018;93(12):E391-E395. doi:10.1002/ajh.25282 - DOI - PMC - PubMed
    1. Kato GJ, Piel FB, Reid CD, et al. . Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010. doi:10.1038/nrdp.2018.10 - DOI - PubMed
    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4)(suppl):S512-S521. doi:10.1016/j.amepre.2009.12.022 - DOI - PubMed
    1. Whiteman LN, Haywood C Jr, Lanzkron S, Strouse JJ, Feldman L, Stewart RW. Primary care providers’ comfort levels in caring for patients with sickle cell disease. South Med J. 2015;108(9):531-536. doi:10.14423/SMJ.0000000000000331 - DOI - PubMed
    1. Haywood C Jr, Diener-West M, Strouse J, et al. ; IMPORT Investigators . Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease. J Pain Symptom Manage. 2014;48(5):934-943. doi:10.1016/j.jpainsymman.2014.02.002 - DOI - PMC - PubMed

Publication types